Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial

This study assessed the efficacy of insulin degludec/liraglutide (IDegLira) vs insulin glargine U100 (IGlar) across categories of baseline glycated haemoglobin (HbA1c; ≤7.5%, >7.5% to ≤8.5% and >8.5%), body mass index (BMI; <30, ≥30 to <35 and ≥35 kg/m(2)) and fasting plasma glucose (FPG...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Obes Metab
Main Authors: Lingvay, Ildiko, Harris, Stewart, Jaeckel, Elmar, Chandarana, Keval, Ranthe, Mattis F., Jódar, Esteban
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2017
Fag:
Brief Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763397/
https://ncbi.nlm.nih.gov/pubmed/28643425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13043
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker